Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 7 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

5Total
Not Applicable (4)
P 2 (1)

Trial Status

Recruiting5
Not Yet Recruiting1
Enrolling By Invitation1

Clinical Trials (7)

Showing 7 of 7 trials
NCT07388745Not ApplicableRecruitingPrimary

ESPB vs SPSIP for Postoperative Analgesia After CABG

NCT07683585Not ApplicableRecruiting

Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention

NCT07407738Not ApplicableRecruitingPrimary

ShockFast Intravascular Lithotripsy Device for Treatment of Calcified Coronary Lesions

NCT07601867Recruiting

Effect of Dapagliflozin on Right Ventricular-Pulmonary Artery Coupling After Off-Pump Coronary Atery Bypass Grafting

NCT07284576Phase 2Enrolling By Invitation

Ultralow Dose PET Imaging of 18F-flurpiridaz

NCT07293858RecruitingPrimary

Optical Coherence Tomography: Prognostic Value and Artificial Intelligence

NCT07109479Not ApplicableNot Yet RecruitingPrimary

Safety and Effectiveness of the Single-Use Coronary Forward Intravascular Lithotripsy Catheter Combined With the Intravascular Lithotripsy Therapy Device

Showing all 7 trials

Research Network

Activity Timeline